Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells

By sjmartinez • January 10, 2025

Wu K, Ge XX, Duan XF, Li JQ, Wang K, Chen QH, Huang ZM, Zhang WY, Wu Y, Li Q. Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells. Drug Resist Updat. 2024 Dec 24;79:101196. doi: 10.1016/j.drup.2024.101196. Epub ahead of print. PMID: 39787991.

Tags: breast cancer, Dephosphorylation, FOXO3a, General Internal Medicine, King Drew Med Ctr, Post Doc, Publications, TRAIL, Wip1

Clonal Hematopoiesis of Indeterminate Potential and Bone Mineral Density in Cohorts from Trans-Omics for Precision Medicine

Kiel DP, Xue W, Xu H, Bick A, Crandall CJ, Hsu YH, Karasik D, Mitchell BD, Montasser ME, Weinstock JS, Wiggins KL, Liu CT, Jackson[...]

Conversational artificial intelligence for geriatric screening: A mixed-methods feasibility study

Naeim A, Cheng J, Spiegel B, Bakshian A, Tetrault E, Mehra M, Amini D, Krut Z, Shang H, Sedrak MS, Bui A, Johnson T, Wang[...]

Inappropriate Patient Behavior: A Survey of Primary Care Providers and Staff at Veterans Health Administration

Relyea MR, Fenwick KM, Klap R, Hamilton AB, Haskell SG, Meredith LS, Yano EM. Inappropriate Patient Behavior: A Survey of Primary Care Providers and Staff[...]